By Abigail Townsend
Date: Wednesday 01 May 2024
(Sharecast News) - Johnson & Johnson has proposed a $6.5bn deal to settle thousands of lawsuits claiming its talc products cause cancer, it was confirmed on Wednesday.
Johnson & Johnson agrees to pay £13bn for Switze... | 28-Apr-2011 | The Independent |
S&N DRIFTS AS BID HOPES SLIP | 19-Apr-2011 | Express & Star |
J&J asks judge to dismiss kickback case | 08-Oct-2010 | Wall Street Journal |
Genzyme Again Rejects Sanofi’s Bid | 08-Oct-2010 | New York Times |
Johnson & Johnson buying vaccine maker Crucell | 07-Oct-2010 | USA Today |
Currency | US Dollars |
Share Price | $ 151.38 |
Change Today | $ 0.16 |
% Change | 0.11 % |
52 Week High | $174.48 |
52 Week Low | $144.45 |
Volume | 51 |
Shares Issued | 2,407.08m |
Market Cap | $364,384m |
RiskGrade | 87 |
Strong Buy | 5 |
Buy | 6 |
Neutral | 11 |
Sell | 0 |
Strong Sell | 0 |
Total | 22 |
Time | Volume / Share Price |
15:59 | 200 @ $151.37 |
15:59 | 100 @ $151.37 |
15:59 | 100 @ $151.37 |
15:59 | 600 @ $151.37 |
15:59 | 100 @ $151.38 |
You are here: research